T. Rowe Price Associates’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.4M | Sell |
|
|||||
|
2025
Q1 | $84.1M | Buy |
|
|||||
|
2024
Q4 | $92.9M | Sell |
|
|||||
|
2024
Q3 | $81.1M | Sell |
|
|||||
|
2024
Q2 | $82.5M | Buy |
|
|||||
|
2024
Q1 | $61.8M | Buy |
|
|||||
|
2023
Q4 | $57M | Sell |
|
|||||
|
2023
Q3 | $53.6M | Buy |
|
|||||
|
2023
Q2 | $58.9M | Buy |
|
|||||
|
2023
Q1 | $49.4M | Sell |
|
|||||
|
2022
Q4 | $64.9M | Buy |
|
|||||
|
2022
Q3 | $51.9M | Buy |
|
|||||
|
2022
Q2 | $48.6M | Buy |
|
|||||
|
2022
Q1 | $63.5M | Buy |
|
|||||
|
2021
Q4 | $61.9M | Sell |
|
|||||
|
2021
Q3 | $66.9M | Sell |
|
|||||
|
2021
Q2 | $68M | Buy |
|
|||||
|
2021
Q1 | $53.2M | Sell |
|
|||||
|
2020
Q4 | $57.3M | Buy |
|
|||||
|
2020
Q3 | $42.9M | Buy |
|
|||||
|
2020
Q2 | $41.1M | Sell |
|
|||||
|
2020
Q1 | $37.1M | Buy |
|
|||||
|
2019
Q4 | $51.4M | Buy |
|
|||||
|
2019
Q3 | $42.6M | Buy |
|
|||||
|
2019
Q2 | $33.3M | Sell |
|
|||||
|
2019
Q1 | $38.9M | Buy |
|
|||||
|
2018
Q4 | $33.1M | Buy |
|
|||||
|
2018
Q3 | $40.6M | Buy |
|
|||||
|
2018
Q2 | $24.3M | Buy |
|
|||||
|
2018
Q1 | $933K | Buy |
|
|||||
|
2017
Q4 | $764K | Sell |
|
|||||
|
2017
Q3 | $553K | Hold |
|
|||||
|
2017
Q2 | $617K | Buy |
|
|||||
|
2017
Q1 | $551K | Buy |
|
|||||
|
2016
Q4 | $329K | Hold |
|
|||||
|
2016
Q3 | $300K | Hold |
|
|||||
|
2016
Q2 | $316K | Hold |
|
|||||
|
2016
Q1 | $315K | Hold |
|
|||||
|
2015
Q4 | $369K | Buy |
|
|||||
|
2015
Q3 | $211K | Hold |
|
|||||
|
2015
Q2 | $262K | Hold |
|
|||||
|
2015
Q1 | $257K | Hold |
|
|||||
|
2014
Q4 | $242K | Hold |
|
|||||
|
2014
Q3 | $201K | Sell |
|
|||||
|
2014
Q2 | $958K | Sell |
|
|||||
|
2014
Q1 | $4.69M | Sell |
|
|||||
|
2013
Q4 | $10.9M | Sell |
|
|||||
|
2013
Q3 | $24.4M | Buy |
|